CAS 322639-20-3

Fórmula: C53H71N13O9

InChI: InChI=1S/C53H71N13O9/c1-3-4-16-39(60-31(2)67)47(70)65-43-29-45(68)57-23-10-9-18-38(46(54)69)61-50(73)42(28-35-30-59-37-17-8-7-15-36(35)37)63-48(71)40(19-11-24-58-53(55)56)62-49(72)41(64-51(74)44-20-12-25-66(44)52(43)75)27-32-21-22-33-13-5-6-14-34(33)26-32/h5-8,13-15,17,21-22,26,30,38-44,59H,3-4,9-12,16,18-20,23-25,27-29H2,1-2H3,(H2,54,69)(H,57,68)(H,60,67)(H,61,73)(H,62,72)(H,63,71)(H,64,74)(H,65,70)(H4,55,56,58)/t38-,39-,40-,41+,42-,43-,44-/m0/s1

Clave InChI: JNEKRCCXHUFBPL-GLEMDPEOSA-N

SMILES: CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C1=O)CC3=CC4=CC=CC=C4C=C3)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N)NC(=O)C

PG-901

CAS: 322639-20-3

PG-901 is a full and selective MC5R agonist, exhibiting an EC50 of 0.072 nM for hMC5R. It also acts as a complete antagonist for hMC3R and hMC4R, with Kb values of 1.0 nM and 0.53 nM, respectively. Additionally, PG-901 significantly reduces the levels of cytokines (IL-1α, IL-1β, and IL-6), enhances glucose tolerance, lowers blood sugar, and mitigates retinal damage.

Fórmula: C₅₃H₇₁N₁₃O₉

Peso molecular: 1034.23

Ref: TM-TP4252